|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,378.00 DKK | -1.18% |
|
+6.66% | -7.67% |
| 05:20pm | Baptista Research Begins Genmab Coverage at Outperform | MT |
| 01/07 | Genmab Announces Changes to Its Executive Committee | CI |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 298.83Cr | 36.44% | 32.53% | 22.97% | 19.34% | -2.97x | ||
| 221.87Cr | 36.99% | -0.96% | 2.26% | 2.02% | 234.49x | ||
| 284.82Cr | -24.18% | -47.77% | -3.3% | -2.88% | 9.36x | ||
| 537.62Cr | 24.08% | 29.51% | 16.78% | 12.27% | -0.97x | ||
| 36Cr | -251.24% | -241.47% | -1,601.19% | -54.47% | 0.16x | ||
| 255.86Cr | 17.97% | 25.37% | 11.65% | 8.43% | -0.66x | ||
| 29Cr | -24.22% | -26.28% | -8.94% | -4.69% | -2.82x | ||
| 216.87Cr | 24.04% | 27.88% | 23.13% | 17.7% | -1.75x | ||
| 26Cr | -13.8% | -7.18% | -9.46% | -9.11% | 3.86x | ||
| 4.19Cr | -410.18% | -365.73% | - | - | - | ||
| 63Cr | -28.22% | -21.76% | -15.45% | -10.06% | 13.02x | ||
| 18Cr | -258.64% | -276.39% | -80.35% | - | 1.63x | ||
| 30Cr | 30.46% | 17.83% | 7.52% | 6.63% | -9.98x | ||
| 49Cr | 40.03% | 45.91% | 30.74% | 24.08% | - | ||
| 178.61Cr | 6.64% | 9.69% | 4.89% | 1.76% | 4.17x | ||
| 24Cr | -85.53% | -78.53% | -54.06% | -26.62% | -1.54x | ||
| Average | 142.08Cr | -54.96% | -54.84% | -110.19% | -1.11% | 17.57x | |
| Weighted average by Cap. | 204.59Cr | -39.79% | -45.13% | -140.26% | -1.17% | 41.58x |
- Stock Market
- Equities
- GMAB Stock
- Sector Genmab A/S
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition